Micro Labs
Micro Labs is a privately held Indian pharmaceutical company, founded in 1973 and headquartered in Bangalore, that manufactures APIs and formulations across 14 cGMP plants and sells branded generics including Dolo-650 to healthcare providers, patients, and distributors in over 50 countries.
- Company typePrivate
- Founded1973
- HeadquartersBangalore, India
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Micro Labs does
Micro Labs Limited is a privately held Indian pharmaceutical company headquartered in Bangalore, founded in 1973 by G.C. Surana and led by the Surana family across Chairman & Managing Director, Director, and Head of Corporate Affairs roles. The company manufactures Active Pharmaceutical Ingredients at a 24,000 square meter facility and produces finished dosage formulations across 14 cGMP-compliant manufacturing plants in India, holding US FDA and UK MHRA accreditations that enable access to regulated international markets.
Micro Labs sells branded generic pharmaceuticals across cardiovascular, anti-infective, neurological, gastrointestinal, and dermatological therapy segments, distributed to over 50 countries with ground-level operations in 25 markets. Its flagship brand, Dolo-650, ranks as the 6th largest brand in the Indian Pharmaceutical Market per AWACS and the number one prescribed paracetamol solid oral brand in India. The company has expanded into OTC wellness under the Micro Wellness sub-brand (pain relief sprays, cough lozenges, thermometers, antacids, nicotine gums) and launched Trisopt, the world's first triple-drug fixed-dose combination for glaucoma management. In October 2024, Micro Labs acquired Nigerian pharmaceutical company Swipha to establish an African foothold.
Revenue is generated primarily through one-time sale of pharmaceutical formulations and APIs to healthcare providers, pharmacies, and other pharmaceutical companies, complemented by OTC retail distribution domestically and through channel partners internationally. Go-to-market combines a field sales force targeting medical practitioners in India with direct international distribution to regulated and emerging markets. The company also functions as a strategic corporate investor, deploying capital into India's venture debt market and regional aviation in late 2025.
Micro Labs firmographics
Firmographics- Name
- Micro Labs
- Legal name
- Micro Labs Limited
- Website
- https://microlabsltd.com
- Company type
- Private
- Founded year
- 1973
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Micro Labs is a privately held Indian pharmaceutical company, founded in 1973 and headquartered in Bangalore, that manufactures APIs and formulations across 14 cGMP plants and sells branded generics including Dolo-650 to healthcare providers, patients, and distributors in over 50 countries.
- Ownership category
- akta.pro rank
Micro Labs industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)
- akta.pro secondary industries
- Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
Keywords
Where Micro Labs is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Micro Labs business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Formulations: Sale of branded generic pharmaceutical drugs including cardiovascular, anti-infective, neurological, gastrointestinal, dermatological, and other therapeutic segments.
- Active Pharmaceutical Ingredients (API): Manufacturing and sale of APIs to other pharmaceutical companies; API unit built over 24,000 square meters.
- OTC/Wellness Products: Over-the-counter products under Micro Wellness brand including pain relief sprays, lozenges, thermometers, antacids, and nicotine gums.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Prescription pharmaceuticals sold to healthcare providers and patients |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Micro Labs product offering
Product offeringCore offering
Micro Labs manufactures and sells Active Pharmaceutical Ingredients (APIs) and finished dosage formulations across multiple therapeutic segments including cardiovascular, anti-infective, neurological, gastrointestinal, dermatological, and diabetes therapies. The company operates 14 cGMP-compliant manufacturing plants in India, holds US FDA and UK MHRA accreditations, and distributes branded prescription pharmaceuticals (e.g., Dolo-650, Trisopt) and OTC wellness products (under the Micro Wellness brand) to over 50 countries with ground operations in 25 countries.
Product overview
Micro Labs is an Indian pharmaceutical company operating as a single unified product portfolio spanning the entire pharmaceutical value chain. The company manufactures Active Pharmaceutical Ingredients (API) at its 24,000 sq meter facility, produces finished dosage formulations across 14 cGMP-compliant plants, and distributes a comprehensive range of branded pharmaceutical products. Key branded products include Dolo-650 (paracetamol, the 6th largest brand in India), Trisopt (world's first triple-drug combination for glaucoma), and multiple cardiovascular and diabetes medications. The company has expanded into the OTC wellness segment under the Micro Wellness sub-brand with products like pain relief sprays, cough lozenges, and thermometers. Through its acquisition of Swipha in Nigeria, Micro Labs has extended its presence into the African pharmaceutical market.
Differentiator
Problem solved
Functional benefit
Brands
- Dolo: Micro Labs' flagship pharmaceutical brand; Dolo-650 (paracetamol) is the 6th largest brand in the Indian Pharmaceutical Market and the number one prescribed brand of paracetamol solid oral doses in India. The brand has been expanded into OTC space including pain relief spray, cough lozenges, and other wellness products.
Products and services
- Dolo-650 Branded paracetamol solid oral dose formulation; the 6th largest brand in the Indian Pharmaceutical Market (per AWACS) and the number one prescribed brand of paracetamol solid oral doses in India. Used by medical professionals and patients for fever and pain relief.
- Trisopt
Quantifiable outcome
- Dolo-650 ranked 6th largest brand in Indian Pharmaceutical Market (per AWACS)
- +1 more outcomes
Companies that use Micro Labs
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles3 records
Micro Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Micro Labs partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Swipha (Swiss Pharma Nigeria Limited)coreMicro Labs acquired Swipha, a leading pharmaceutical company in Nigeria, to expand its footprint across the African continent. The acquisition improves supply chain efficiency, broadens treatment options, and facilitates product export to neighboring countries.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Micro Labs competitors and assessment
Company assessmentDirect peers
- Mankind Pharma: Indian branded generics company with comparable therapeutic breadth and a similarly aggressive OTC/consumer wellness strategy (e.g., Manforce, Prega News). Closest analog to Micro Labs in terms of domestic prescription strength and OTC brand extension.
- Alkem Laboratories: Indian pharma company with a comparable branded-generics portfolio spanning anti-infectives, cardiology, GI, and dermatology, plus manufacturing scale across multiple cGMP plants. Closely matches Micro Labs on therapeutic mix and domestic prescription footprint.
- Torrent Pharmaceuticals: Mid-sized Indian pharma with a strong branded generics portfolio in cardiovascular, diabetes, and CNS — overlapping heavily with Micro Labs' cardiovascular (Amlong/Arbitel) and diabetes (Diapride/Tripride) franchises.
- JB Chemicals & Pharmaceuticals: Indian branded generics player with similar scale, multi-therapeutic presence, and growing OTC/consumer health line. Comparable in plant footprint and regulatory maturity to Micro Labs.
- Ipca Laboratories: Indian pharma manufacturer with overlapping therapeutic areas (anti-infectives, cardiovascular, pain management) and parallel API manufacturing capabilities — directly comparable vertically integrated model to Micro Labs.
- Emcure Pharmaceuticals: Mid-sized Indian pharma with comparable branded generics footprint across women's health, cardiology, and anti-infectives, plus growing international presence. Closely matched in scale and ambition to Micro Labs.
Broad incumbents
- Cipla: Large incumbent Indian pharma with a much broader portfolio and global footprint but overlapping therapeutic segments (respiratory, cardiovascular, anti-infectives). Sets the competitive ceiling on branded generics in India.
- Sun Pharmaceutical Industries: India's largest pharma company, dominant in chronic therapy branded generics including cardiology and neurology — segments where Micro Labs also competes. Sets pricing and doctor-engagement benchmarks.
- Dr. Reddy's Laboratories: Major Indian pharma with parallel API + generics model and significant regulated-market exports (US, EU). Comparable API manufacturing depth to Micro Labs' 24,000 sqm API facility.
- Lupin Limited: Large Indian pharma with strong branded generics in cardiovascular, anti-infectives, and diabetes — all therapeutic pillars where Micro Labs operates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Micro Labs social profiles
Digital presenceMicro Labs compliance and trust
Trust signalCompliance3 records
Micro Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Micro Labs leadership team
Management profileNumber of profiles
Profiles4 records
Micro Labs subsidiaries and ownership
Company hierarchySubsidiaries1 record
Micro Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Micro Labs M&A and investment
M&A and investmentM&A1 record
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Micro Labs
What does Micro Labs do?
Micro Labs manufactures and sells Active Pharmaceutical Ingredients (APIs) and finished dosage formulations across multiple therapeutic segments including cardiovascular, anti-infective, neurological, gastrointestinal, dermatological, and diabetes therapies. The company operates 14 cGMP-compliant manufacturing plants in India, holds US FDA and UK MHRA accreditations, and distributes branded prescription pharmaceuticals (e.g., Dolo-650, Trisopt) and OTC wellness products (under the Micro Wellness brand) to over 50 countries with ground operations in 25 countries.
Is Micro Labs a public or private company?
Micro Labs is a private company. It is classified as family owned and is currently operating.
When was Micro Labs founded?
Micro Labs was founded in 1973. It employs 5,001 to 10,000 people.
Where is Micro Labs based?
Micro Labs is headquartered in Bangalore, India, in the Asia region.
How does Micro Labs make money?
Three revenue lines are on record. Pharmaceutical Formulations are the primary driver. The others are active Pharmaceutical Ingredients (API) and OTC/Wellness Products.
Who are Micro Labs's main competitors?
Direct peers on record are Mankind Pharma, Alkem Laboratories, Torrent Pharmaceuticals, JB Chemicals & Pharmaceuticals, Ipca Laboratories and Emcure Pharmaceuticals. Broad incumbents are Cipla, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories and Lupin Limited.
Does Micro Labs have an API?
No public API is recorded for Micro Labs.
What industry is Micro Labs in?
Micro Labs's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity), with a secondary code of HLAIACAG, Cardiology & Vascular Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.